Series D - FogPharma

Series D - FogPharma

Investment Firm

Overview

FogPharma is a biopharmaceutical firm that develops precision medicines for the vast majority of therapeutic targets.

Announced Date

Nov 21, 2022

Funding Type

Series D

Highlights

Location

United States, North America

Social

Investor Lead

N/A

Participant Investors

11

Investor Name
Participant InvestorInvus
Participant InvestorGoogle Ventures
Participant InvestorARCH Venture Partners
Participant InvestorFidelity
Participant InvestorFarallon Capital Management

Round Details and Background

FogPharma raised $178000000 on 2022-11-21 in Series D

FogPharma is a biopharmaceutical firm that develops precision medicines for the vast majority of therapeutic targets.

Company Funding History

6

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Nov 21, 2022
Series D - FogPharma
13-178.0M
Jan 04, 2021
Venture Round - FogPharma
-23.3M
Mar 01, 2024
Series E - FogPharma
20-145.0M
Jun 07, 2016
Series A - FogPharma
1-11.0M

Recent Activity

There is no recent news or activity for this profile.